The right to survive select="/dri:document/dri:meta/dri:pageMeta/dri:metadata[@element='title']/node()"/>

DSpace Repository

Show simple item record

dc.contributor.advisor Asp Inger en_US
dc.contributor.advisor Lindvall Jan en_US
dc.contributor.author Hallgren Sofia en_US
dc.date.accessioned 2013-07-02T14:11:19Z
dc.date.available 2013-07-02T14:11:19Z
dc.date.issued 2004. en_US
dc.identifier.uri http://hdl.handle.net/11070.1/4775
dc.description.abstract Abstract by author: en_US
dc.description.abstract The analysis of the empirical findings is based on the Structure-Conduct-Performance model. This model has been chosen because it provides a good over- view over the different factors that influence the access en_US
dc.description.abstract In Namibia around 20 percent of the population is infected with HIV and only a small part of thesepeople have access to antiretroviral-drugs (ARV-drugs), a life prolonging treatment for people living with HIV. Most of the people currently on treatment are part of the government treatment program, where the government is covering the cost of the treatment. Very few people in Namibia can afford to pay for the treatment themselves en_US
dc.description.abstract There is lot that can be done to improve the competition on the Namibian market. The number of sellers could be higher and there are also entry barriers that could be removed in order to decrease the price. But the fact is that even if the prices were lower most people would not be able to afford the treatment by themselves anyway. Instead it seems more important to lower other costs connected to the treatment. Because of the stigma connected to HIV/Aids in Namibia many people do not consider it worth taking the risk of disclosing their HIV-status and therefore they do not seek treatment. The stigma and the lack of information appear to be the two major reasons to why people do not go for treatment. Many people do not know that treatment exists. Many people are also forced to travel long distances to the hospitals which also results in high general costs en_US
dc.description.abstract A consequence of these factors is that there is no significant demand for the ARV-drugs. A higher demand would put more pressure on the government to make treatment more available. There seems to be a need for some sort of pressure group who could force the government to speed up the process of increasing the access to treatment. However, it is doubtful if the government will be able to keep on providing treatment for those who need it. This will require enormous resources that the government does not have. When people instead of dying in HIV/Aids will keep on constituting a cost for the healthcare system, because of the treatment, this will increase the amount of resources needed even further. Therefore it is important that everybody within the society takes their responsibility to make the treatment more available en_US
dc.format.extent 37 p en_US
dc.language.iso eng en_US
dc.subject Hiv/aids en_US
dc.subject Health care en_US
dc.subject Medicine en_US
dc.title The right to survive en_US
dc.type thesis en_US
dc.identifier.isis F004-199299999999999 en_US
dc.description.degree Linköping en_US
dc.description.degree Sweden en_US
dc.description.degree University of Linköping en_US
dc.description.degree B Sc? en_US
dc.masterFileNumber 3083 en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record